Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL | T.CRDL.W.A

Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, cardiovascular disease. Cardiol has also received clearance from the Food and Drug Administration (FDA) for its investigational new drug (IND) application for a Phase II international trial that investigates the anti-inflammatory and anti- fibrotic properties of CardiolRx in patients with acute myocarditis, which is a common cause of sudden cardiac death in people under 35 years of age. In addition, Cardiol is developing a subcutaneous formulation of CardiolRx and other anti-inflammatory therapies for the treatment of chronic heart failure.


TSX:CRDL - Post by User

Post by GiveMeMoneyon Mar 12, 2021 8:22pm
150 Views
Post# 32791423

...are its eyes opening, or is it permanent 'x's' there?

...are its eyes opening, or is it permanent 'x's' there?i was just noting that if you were to have listened to any sh&t-head analyst in DECEMBER 2019, you'd be getting your money back, just now!

x's in its eyes or has it somehow gained some hollow sentiment!

or maybe just a terrible returning mule with rabies. ...all that hype...all that hype...

and we still haven't found out how many blind people have been shusted out of $399 bottles of WHATEVER which will probably not be too many and then it will be like someone ate mexican chilli and split its pants.THE ROOM WILL CLEAR!!!!

all that hype, all that hype, for our little darling cdn pharma company, with big dreams... (Gonna get there gonna get there gonna get there gonna get there...)

I haven't looked at this thing in weeks AND NOTHING'S CHANGED!!!
<< Previous
Bullboard Posts
Next >>